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Abstract
Background: Molecular chaperones help to restore the native states of proteins after their 
destabilization by external stress. It has been proposed that another function of chaperones is to 
maintain the activity of proteins destabilized by mutation, weakening the selection against 
suboptimal protein variants. This would allow for the accumulation of genetic variation which could 
then be exposed during environmental perturbation and facilitate rapid adaptation.
Results: W e  focus on studies describing interactions of chaperones with mutated polypeptides. 
There are some examples that chaperones can alleviate the deleterious effects of mutations 
through increased assistance of destabilized proteins. These experiments are restricted to bacteria 
and typically involve overexpression of chaperones. In eukaryotes, it was found that the 
malfunctioning of chaperones aggravated phenotypic aberrations associated with mutations. This 
effect could not be linked to chaperone-mediated stabilization of mutated proteins. More likely, the 
insufficient activity of chaperones inflicted a deregulation of multiple cellular systems, including 
those responsible for signaling and therefore important in development. As to why the assistance 
of mutated proteins by chaperones seems difficult to demonstrate, we note that chaperone- 
assisted folding can often co-exist with chaperone-assisted degradation. There is growing evidence 
that some chaperones, including those dependent on Hsp90, can detect potentially functional but 
excessively unstable proteins and direct them towards degradation instead of folding. This implies 
that at least some mutations are exposed rather than masked by the activity of molecular 
chaperones.
Conclusion: It is at present impossible to determine whether molecular chaperones are mostly 
helpers or examiners of mutated proteins because experiments showing either of these roles are 
very few. Depending on whether assistance or disposal prevails, molecular chaperones could speed 
up or slow down evolution of protein sequences. Similar uncertainties arise when the concept of 
chaperones (mostly Hsp90) as general regulators of evolvability is considered. If the two roles of 
chaperones are antagonistic, then any (even small) modification of the chaperone activities to save 
mutated polypeptides could lead to increased misfolding and aggregation of other proteins. This 
would be a permanent burden, different from the stochastic cost arising from indiscriminate 
buffering of random mutations of which many are maladaptive.
Reviewers: This article was reviewed by A. S. Kondrashov, J. Hohfeld (nominated by A. Eyre- 
Walker) and D. A. Drummond (nominated by C. Adami). For the full reviews, please go to the 
Reviewers' comments section.
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Background
The phenotype often remains stable in spite of extensive 
variation in the genetic material [1,2]. This has been dem­
onstrated in experiments in which many genes were 
deleted [3-6] or mutated [7,8]. It has been proposed that 
such genetic robustness may be an adaptation because it 
reduces phenotypic penetration of deleterious mutations 
[9,10]. This concept is still under debate and its full com­
prehension will require detailed study of the underlying 
mechanisms [11]. It has been suggested that molecular 
chaperoning may be one of these mechamisms [12]. 
Chaperoning is carried out by molecules originally 
denoted as heat shock proteins (Hsps). They are especially 
abundant in cells subject to environmental stress in which 
they help to reactivate destabilized and/or aggregated pro­
teins [13-16]. Most chaperones are also present in nor­
mally growing cells [17,18]. Under these conditions, 
random misfolding is especially likely to affect proteins 
that mutated in such a way as to reduce their structural sta­
bility. Regardless of whether the source of damage is envi­
ronmental or mutational, its effect on a protein is similar. 
Hydrophobic regions of a polypeptide, normally buried 
inside the protein, become exposed on its surface. This is 
a signal of protein damage, recognized universally by a 
variety of molecular chaperones [19,20]. Through binding 
and release of the destabilized proteins, the chaperones 
perform a dual action: they ameliorate the danger that 
proteins will aggregate via the hydrophobic patches and 
promote the refolding of proteins to their native structures 
[21-24]. It seems straightforward to assume that because 
the protein signal and the chaperone reaction are univer­
sal, the overall effect o f chaperoning is also universal. That 
is, since the chaperones are known to maintain activity of 
proteins affected by stress, they should also support func­
tioning of proteins destabilized by mutation. The notion 
that molecular chaperones are potent and general agents 
of genetic robustness has gained wide recognition [11]. Its 
experimental corroboration has been sought in studies 
involving both bacteria [25-27] and eukaryotes [12,28]. 
In general, these experiments show that abnormal pheno­
types become more evident when cellular levels of chap­
erones decline. However, such results only hint at the 
possibility that the observed phenotypic changes result 
from the poor performance of mutated proteins when the 
required (re)folding activity of chaperones is insufficient 
[12,25-28]. An alternative explanation is that malfunc­
tioning of the molecular chaperones leads to malfunc­
tioning of many non-mutated proteins [29]. As it is 
explained later in more detail, the inflicted epistatic effects 
can match or even exceed those associated with the muta­
tions destabilizing proteins. Therefore, it is necessary to 
discriminate carefully between these two different aspects 
of chaperone activity.
A reevaluation of the role of chaperones in evolution 
appears unavoidable in light of key developments in 
research on molecular and cellular functions of these pro­
teins. Over the two last decades, they were found to par­
ticipate in a wide spectrum of cellular processes. 
Molecular chaperones are known to assist folding of both 
nascent and nearly mature proteins, as well as protein 
translocation, remodeling, secretion, and degradation 
[30]. Although chaperones engaged in these processes are 
diverse and often non-homologous, they all recognize 
their protein substrates in a generally similar way, i.e. by 
direct binding to hydrophobic surfaces. However, under 
normal cellular metabolism the binding of a destabilized 
protein by a chaperone is often only the first step in its fur­
ther processing. The polypeptide can then be released and 
allowed to continue its folding. However, the chaperones 
may also stop or revert folding of a protein to enable its 
translocation or modification [30]. A particularly intrigu­
ing possibility is that some of the most abundant chaper­
ones recognize excessively unstable proteins and direct 
them towards degradation [31,32]. Originally discovered 
as agents devised specifically to rescue misfolded proteins, 
chaperones were then found to participate actively in 
quality control and disposal of troubled chains in order to 
prevent toxic interactions among themselves and with 
other cellular elements. In this perspective, the chaper­
ones are helpers at the time of stress, but can become 
examiners at the time of normal metabolism, While this is 
not new for molecular biologists (recently reviewed in 
[33-36]), it has not been considered in relation to pheno­
typic masking and genetic robustness [12,28,29,37].
Central to this article will be the question of how the activ­
ity of chaperones affects the strength of purifying selec­
tion. We accept the opinion that molecular chaperones 
have a generally stabilizing effect on genetic networks and 
that mutations are more likely buffered when the net­
works are robust. Our focus will be on direct interactions 
between the chaperones and mutated proteins. In particu­
lar, we ask when and how the action of molecular chaper­
ones can be diverted from rescue to disposal of 
destabilized proteins and whether this may influence the 
rate and mode of protein evolution.
M olecular chaperones and phenotypic buffering 
in bacteria
Thermally induced instability is only one possible cause 
of protein misfolding. Others include overcrowding, tran­
scriptional and translational errors, absence of necessary 
post-translational partners for proteins, and different 
chemical and physical stresses. Overcrowding seems to be 
especially important and universal because the density of 
macromolecules (proteins and RNAs) within cells is very 
high, typically about 300 g/l [38]. These conditions neces­
sarily promote frequent misfolding and aggregation of
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(A )  Chaperone assisted folding of nascent and newly synthesized proteins in bacteria [34]. An elongating polypep­
tide is initially shielded by TF (trigger factor), a chaperone attached near the exit of the ribosomal tunnel. DnaJ (bacterial 
Hsp40) initiates binding of the polypeptide by DnaK (Hsp70) during translation. The initial, co-translational assistance of these 
chaperones is sufficient for the folding of many proteins (upper path). Other proteins are chaperoned by DnaK also after they 
detach from the ribosome (middle path). There are also proteins whose post-translational folding is assisted by DnaK and then 
by the GroEL/ES system. (B )  Chaperone assisted reactivation of secondarily misfolded bacterial proteins. An unfolded protein 
can be rescued or directed to proteolysis. Participation of the molecular chaperones in recruiting single chains from aggrega­
tion and then in their correct folding is well documented. Possible cooperation of the chaperones with proteases has also been 
reported (see the text for more details). In bacteria, folding of both the primarily and secondarily unfolded proteins is assisted 
by the same chaperones.
polypeptides [39], especially in regions of intense transla­
tion because elongating chains remain largely unfolded 
until synthesis of a whole protein domain is finished [40]. 
Translational errors represent another important factor 
promoting misfolding because they are inherent to bio­
synthesis and occur at a considerably high rate, between 
1/1,000 and 1/10,000 per codon, which may lead to 
improper amino acids sequences in up to 20% of 
polypeptides [41]. Bacteria have evolved a chaperone sys­
tem that assists folding of nascent proteins. Its three major 
constituents iclude TF, DnaK, and GroEL (Fig. 1A). TF is 
bound to the ribosome and provides initial shielding to 
an elongating polypeptide [42]. DnaK is a typical Hsp70 
chaperone that recognizes short stretches of hydrophobic 
amino acids which are expected to occur at multiple posi­
tions of most proteins [19]. Individually acting molecules 
of DnaK bind and release polypeptides in a cycle governed 
by its two cofactors, DnaJ and GrpE [43]. This helps to 
unwind and separate intertangled molecules and in this 
way facilitates proper folding. The Hsp60 type chaperone 
GroEL works in a different way. It oligomerizes into hep- 
tamers forming ring-shaped cages with hydrophobic api­
cal regions. These recognize the hydrophobic parts of 
substrates which are then, with the help of a smaller chap­
erone partner GroES, translocated to the interior where 
their folding can be completed without danger of interfer­
ence by other proteins [20]. DnaK and GroEL bind not 
only the nascent proteins but also those secondarily mis- 
folded and aggregated, both under normal metabolism 
and stress [44-46], (Fig. 1B). They are always abundant 
and taken together form the core of the bacterial chaper­
one machinery [24]. The bacterial cell also hosts other 
chaperones but these two are most likely to be involved in 
phenotypic buffering of genetic variation.
Elevated levels of the GroEL type chaperone are found in 
the endosymbiotic bacteria Buchnera. It has been sug­
gested that this is an adaptation to a high incidence of 
mutational destabilization of proteins in these bacteria. 
They live inside cells in small populations, making natural 
selection inefficient in removing slightly deleterious 
mutations from protein coding genes [25]. To test this 
hypothesis, laboratory populations of E. coli with experi­
mentally accumulated multiple deleterious mutations 
were used. It was found that the mutated clones grow bet­
ter under induced overexpression of the chaperones 
GroEL or DnaK [26]. In another experiment involving E. 
coli, mutations were gradually accumulated. Clones that
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survived had enhanced levels of DnaK and GroEL [27]. 
The latter finding is especially interesting, because it sug­
gests that an increase in mutational load selects for a con­
current increase in the cellular level of chaperones. 
However, among the tens or even hundreds of mutations 
involved in this and the two former studies, there must be 
some that reduced the level of expression and not the 
structural stability of proteins. Lowered levels of these 
proteins could create rate limiting steps in cellular metab­
olism. Assuming that some of these proteins require chap­
erones for maturation or remodeling [47,48], increased 
levels of the chaperones would probably be advanta­
geous. Hypothetically, this, and not the need to support 
structurally destabilized proteins, could be the reason why 
natural selection favors high levels of chaperones. 
Another interesting result was obtained in a study in 
which an induced overexpression of GroEL resulted in 
suppression of single heat-sensitive mutations, but not 
cold-sensitive or temperature insensitive ones [49]. 
Because heat sensitivity typically accompanies protein 
instability, this result is close to demonstrating that chap­
erones can restore the functionality of mutationally desta­
bilized proteins and thus provide means for phenotypic 
masking in its clearest form. Still better evidence for this 
comes from experiments with temperature sensitive 
mutants of the coat protein of the phage P22. Mutated 
protein is unstable and tends to misfold and aggregate. It 
was explicitly shown that GroEL/S interacted in vivo with 
the mutated proteins significantly more intensely than 
with wild-type protein. Normal levels of the chaperone 
were sufficient to save most of the mutated protein from 
aggregation at low temperatures. At standard and higher 
temperatures, aggregation was curbed by artificial overex­
pression of the chaperone [50]. This example shows that 
there are proteins which become dependent on molecular 
chaperones after mutation and suggests that bacterial cells 
may increase their buffering capabilities by increasing the 
cellular level of molecular chaperones. At this point, it is 
appropriate to ask how the upregulation of chaperones 
may affect the functioning of other, non-mutated ele­
ments of cellular metabolism.
Molecular chaperones are often viewed as competitors to 
proteases as both of these classes of enzymes recognize 
destabilized proteins. Normally more abundant, the 
chaperones are likely to bind transiently most structurally 
defective proteins and promote their folding, thereby pre­
venting degradation [51]. Interactions with the chaper­
ones would be important for the mutated proteins, 
especially if they extend over multiple rounds of binding 
and release, because this could salvage them from pro­
teases. However, even if activity of bacterial chaperones 
strictly opposes that of proteases, it is still possible that 
under normal growth the quality control system is bal­
anced at a level of sensitivity appropriate for folding of
wild-type but not mutated proteins. Indeed, at least some 
mutationally destabilized proteins are rapidly degraded 
under normal cellular concentration of DnaK [52]; recall 
that stabilization of mutated proteins was observed when 
chaperones were overexpressed [49]. Moreover, there is 
evidence that a bacterial chaperone (DnaJ) can aid bacte­
rial proteases (Lon and ClpAP) in the degradation of a 
mutationally destabilized protein and that this support is 
not restricted to maintaining the protein in a soluble state 
[53] but is likely to take more active forms [54]. Similarly, 
there is indication that if GroEL fails to catalyze the proper 
folding of a protein, it can facilitate its rapid degradation 
[55]. Overexpression of molecular chaperones is likely to 
interfere with protein degradation. Moreover, overex­
pressed chaperones change the range of proteins with 
which they interact [56]. Thus, it is likely that permanent 
change in the cellular level of chaperones may result in 
negative fitness effects, especially in nature with its exten­
sive environmental fluctuations. On the other hand, it 
must be remembered that even significant reduction [50] 
or extreme increase [26] in the level o f crucial bacterial 
chaperones, such as GroEL/S, leave the cells viable under 
the laboratory conditions.
In conclusion, both the genetic data and molecular mod­
els suggest that chaperone-mediated masking of protein 
structural instability in bacteria is possible. However, the 
activity of molecular chaperones appears fine tuned to 
avoid interference with the protein quality control and 
multiple other processes. It is not yet possible to estimate 
how frequently the chaperone-mediated phenotypic 
masking actually works. However, it appears legitimate to 
postulate that in bacteria molecular chaperones may occa­
sionally facilitate fixation of a partially deleterious muta­
tion by alleviating its negative phenotypic effects. This 
may involve transient or sustained increase in the cellular 
level of chaperones, but the associated costs need not be a 
long term evolutionary handicap if populations are effec­
tively small, making selection relatively inefficient.
M olecular chaperones and phenotypic buffering 
in eukaryotes
The problem of molecular overcrowding is no less acute in 
eukaryotes. Eukaryotic chaperones are to a large extent 
homologous to those known in bacteria, although they 
are more numerous, diverse, and specialized. In particu­
lar, they probably constitute two major networks, one 
active at the time of stress, and the other associated with 
the production and maturation of new proteins. Accord­
ingly, expression of the former is correlated with reaction 
to stress and that of the latter with the intensity of transla­
tion [57]. This article focuses on the network associated 
with protein synthesis because these chaperones work 
throughout most of the lifetime of eukaryotes and there­
fore are more relevant to phenotypic masking of muta­
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tions. As in bacteria, there are cytosolic Hsp70 chaperones 
that bind elongating polypeptides already during transla­
tion. After their synthesis is complete, some proteins are 
released by the chaperones and ready to function. Others 
remain bound to the Hsp70 molecules which direct them 
to more specialized folding machines, e.g. TRiC (a ring­
shaped octamer, homologous to bacterial GroEL) or 
Hsp90. It appears that the folding of a nascent protein is 
continuously escorted by molecular chaperones, begin­
ning with the moment when its N-terminus leaves the 
ribosome's tunnel and ending when its final or nearly 
final three-dimensional structure is formed [18]. Indeed, 
most destabilized proteins must be sequestered by the 
molecular chaperones because there are relatively few 
unfolded or partially unfolded polypeptides in the cytosol 
[58]. Consistent with this, it has been found that at most 
a few percent of polypeptides are degraded shortly after 
synthesis, suggesting that most are protected from proteo­
lytic enzymes [59]. Thus, at least in the eukaryotic cell, the 
newly synthesized and secondarily destabilized proteins 
do not form a sizable pool of free molecules that is con­
stantly bound and released by the chaperones. Rather, 
they are passed along defined pathways of assisted folding 
[18]. The question is whether the chaperones participat­
ing in these pathways work to bring a mutated protein to 
a structure that is functionally active even if its stability is 
reduced.
The folding of proteins in the eukaryotic cell can be 
divided into an early phase, common to and similar for 
many proteins, and a late phase, constrained to special 
types of proteins (Fig. 2A). The early phase starts during 
translation when the Hsp70 chaperones bind an elongat­
ing polypeptide chain. This phase is functionally sepa­
rated from other chaperone activities because it is initiated 
by specialized Hsp40 chaperones that are bound to ribos­
omes and direct Hsp70 molecules to a nascent protein 
[60]. In yeast, both the co-translationally acting Hsp40 
and Hsp70 are distinct from other proteins of these types 
present in the cell [61,62]. Deletion of genes coding for 
these proteins does not affect the yeast cell's viability. This 
raises the question of what is the phenotypic expression of 
mutations when the co-translational system of chaper­
ones is or is not active. This question is especially impor­
tant because the chaperones participating in translation 
are likely to bind many if not all newly synthesized pro­
teins [57]. To answer this, an array of thermally sensitive 
(protein destabilizing) mutations in different genes was 
tested. The expectation that the phenotypic effects of pro­
tein malfunctioning will be more severe in the chaperone- 
deficient cells was not confirmed [63]. This result falsifies 
the hypothesis of chaperone-mediated masking of muta­
tional effects in its strongest form, stating that virtually all 
chaperones able to bind unwound proteins will in effect 
support their proper folding [64].
The phenotypic masking of mutations was extensively 
studied in late-folding chaperones. In eukaryotes, some 
proteins, including those participating in cellular signal­
ing and regulation, require the assistance of the Hsp90 
chaperone in order to finish their folding and to attain a 
functionally active structure (Fig. 2B) [65]. Hsp90 can be 
partially inactivated by geldamycin. In fruit flies and 
plants, such treatment results in phenotypic differentia­
tion of individuals whose parents, although phenotypi­
cally alike, are genetically different. The new phenotypic 
variants can be fixed in selection experiments. Some do 
not need further pharmacological stimulation to endure 
[12,28]. In this way, the basic assumptions of evolution- 
arily relevant phenotypic masking have gained support. 
First, genetic variation can be covered up under a com­
mon phenotype through the activity of the Hsp90 chaper­
one. Second, the variation can escape the masking effect 
o f the chaperone (in natural environments this may be 
accomplished by stress) and serve as raw material for her­
itable adaptation. These findings, comprehensive at the 
level of genetic analysis, have not been further supported 
by deciphering the underlying molecular mechanisms
[29,37,64,66]. It is also worth noting that some other 
experiments with fruit flies have shown that the buffering 
effect o f Hsp90 is neither as universal nor as strong as orig­
inally believed [67,68]. To further discuss this issue, it is 
necessary to introduce the concept of protein quality con­
trol in eukaryotic cells.
Chaperones in eukaryotic protein quality  
control
The native structure of a protein is only one of a great 
number of conformations that can be adopted by a 
polypeptide extending over hundreds of amino acids. 
Non-native spatial structures of non-mutated polypep­
tides generally occur in two situations, during and shortly 
after synthesis, and after the destabilization of a mature 
protein. Protein structural stability may also be altered 
because of errors arising at transcription or translation. 
Damaged proteins are marked for disposal by ubiquityla- 
tion and then degraded by proteasomes [69]. The accuracy 
of the cellular systems recognizing incorrect structures and 
their ability to discriminate between transiently misfolded 
wild type chains and those permanently changed by 
mutation are still insufficiently known. O f special interest 
is the proposition that the molecular chaperones can 
cooperate actively with the ubiquitin/proteasome system 
in selecting structurally unstable proteins for degradation 
[31,32]. If true, this would mean that eukaryotic chaper­
ones do not invariably support the functioning of the 
defective proteins, including those mutated.
A well studied example of cooperation between molecular 
chaperones and a protein degradation system is the qual­
ity control of proteins in endoplasmatic reticulum (ER).
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Figure2
Chaperone-assisted folding of proteins in eukaryotes [3 4 ].(A ) Early phase of folding of newly synthesized proteins. 
Hsp40 molecules attached to ribosomes (rHsp40) activate cytosolic Hsp70 molecules and direct them to elongating polypep­
tides. This co-translational chaperoning may be sufficient for the correct folding of many proteins. Folding of some others is 
assisted by Hsp70 also post-translationally. This can require collaboration of Hsp70 (or prefoldin, not shown) with TRiC. 
Finally, Hsp70 can direct some proteins to Hsp90, which initiates the late phase of folding. (B )  Late phase of protein folding and 
protein quality control in eukaryotes. A  protein held by Hsp70 can be released and free from further assistance of the chaper­
ones providing that it manages to adopt a proper conformation. In case of excessively unstable proteins, Hsp70 can recruit the 
co-chaperones CHIP and BAGI and this eventually leads to protein degradation in the proteasome. Some special proteins are 
transferred from Hsp70 to Hsp90 with the help of the co-chaperone HOP. Successfully transferred protein is held by Hsp90 
which enables its final modification; alternatively, the protein is directed to proteolysis. The binding by Hsp70 is typical both for 
newly synthesized and secondarily misfolded polypeptides. If the latter happens, the binding of Hsp70 to polypeptides is gov­
erned by Hsp40 chaperones other than those attached to ribosomes. This is one way to differentiate the specificity and inten­
sity of the eukaryotic chaperone activity between normal metabolism (protein synthesis) and stress reaction (protein 
reactivation).
Apart from chaperones specialized in the control of the 
ER-specific protein modifications, there exists a chaper­
one system attending the primary control of general sta­
bility. In mammals, it is based on BiP, a member of the 
Hsp70 family. This protein binds nascent and newly syn­
thesized proteins after their co-translational translocation 
through the ER membrane and assists folding in the 
lumen. BiP recognizes a variety of proteins and apparently 
interacts most intensely with slow or atypical folders [70]. 
Correctly folded proteins proceed to further modifica­
tions and export, defective ones are retained in the ER and 
then are unfolded and ubiquitylated while being translo­
cated through the membrane on their way to cytosolic 
proteasomes [30,71,72]. It has been shown for a series of 
thermally sensitive mutants of ER proteins that the inten­
sity of their eradication increases with greater instability of
the mutants [73,74]. Thus, these molecular chaperones 
sense the folding problems, cannot overcome them, and 
facilitate the degradation of the troubled proteins.
The Hsp70 chaperones serve as detectors of general fold­
ing problems also in the eukaryotic cytosol. Normal pro­
teins experience routine binding by the chaperones; in 
such cases, a likely scenario is that co-chaperones called 
'nucleotide exchange factors' will help to release timely 
the protein from the chaperones [43,75,76]. Proteins that 
exhibit substantial structural instability are likely passed 
from the chaperones to proteases. For example, a mutated 
form of CFTR (cystic fibrosis transmembrane conductance 
regulator) shows prolonged interaction with the cytosolic 
Hsp70 system which probably constitutes a signal for its 
ubiquitylation and degradation [77,78]. Covalent attach­
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ment of ubiquitins is performed by ubiquitin-conjugating 
enzymes, E2, and ubiquitin ligases, E3 [69]. E3 ligases are 
especially important for protein quality control because 
they are responsible for selection of polypeptides destined 
for ubiquitylation. It has been shown that one of such 
ligases, CHIP, is effectively a co-chaperone of Hsp70. It 
docks to the Hsp70 chaperone that holds a misfolded pro­
tein, recruits an E2 enzyme and triggers the ubiquitylation 
of the protein. Two further steps are performed by a single 
protein, BAG-1, another co-chaperone of Hsp70. It links 
the chaperone to a proteasome and releases the ubiqit- 
ylated polypeptide so it can be transferred from the former 
to the latter [31,32]. The whole model is impressively 
complete in its functional and structural aspects. Under­
standably, it serves as the chief example of cooperation, 
instead of competition, between cytosolic chaperones and 
proteases.
CHIP-mediated protein quality control and degradation 
has been demonstrated for several different proteins [32]. 
Still, it is not clear whether most destabilized proteins are 
detected and disposed in this way. Notably, there is no 
known homologue of CHIP in the budding yeast which 
therefore must apply a different interface between the 
chaperones and the proteases. Recently, a new example of 
a cytosolic chaperone-mediated system of decision mak­
ing concerning folding or degradation has been described. 
The folding of a newly synthesized mammalian cytosolic 
protein, VHL tumor suppressor, requires that Hsp70 
cooperates with TRiC. When the folding is defective, 
Hsp70 transfers the protein to a chaperone complex that 
includes Hsp90 and this eventually leads to degradation 
of VHL. The two pathways are distinct: TRiC is required 
for folding but dispensable for degradation, the reverse is 
true for Hsp90. Hsp70 is at the crossroads, its activity is 
necessary for both functions [79]. This system, and that 
dependent on CHIP, have much in common. Both 
assume that a troubled protein is first recognized and 
bound by the Hsp70 chaperone and that the outcome of 
this event depends on subsequent interactions between 
the protein, Hsp70, and other chaperones and co-chaper­
ones.
It is likely that other chaperone systems also participate in 
the broadly defined quality control of proteins. It has 
already been mentioned that an experimental attempt to 
demonstrate that the yeast co-translational Hsp40/70 sys­
tem can support the functioning of mutationally destabi­
lized proteins was unsuccessful [63]. This result becomes 
comprehensible when protein quality control is taken 
into account. The Hsp70 chaperones are present on the 
pathways leading either to protein folding or protein dis­
posal. Apparently, proteins that contain mutations caus­
ing defects large enough to produce thermo-sensitive 
phenotypes are directed mostly to the second path (Fig.
3). Indeed, ongoing experiments show that the in vivo 
activity of mutated proteins is actually less efficient when 
the Hsp40/70 system is active. This suggests that the chap­
erones participate in sorting out the defective molecules 
(Tomala and Korona, unpublished). It has been postu­
lated that the general purpose of co-translational chaper­
ones is to enhance the efficiency of protein folding [18]. 
However, it is also plausible that not low folding effi­
ciency but the danger of formation of toxic misfolded 
and/or aggregated species is the ultimate reason why the 
newly synthesized proteins are chaperoned [57,80]. In 
both cases, but especially in the latter, the co-translational 
chaperones would rather expose than conceal genetic 
defects because their function would be to scrutinize the 
folding of gene products which would result in preferen­
tial elimination of mutants.
The quality of proteins maturing in the ER is strictly con­
trolled both in terms of general stability and correctness of 
specific modifications [72,81]. The hypothesis of pheno­
typic buffering of mutational damage by the molecular 
chaperones has never been explicitly applied to these pro­
teins. Therefore ER proteins, comprising a large share of 
all proteins present in the eukaryotic cell, will not be fur­
ther taken into account as potential subjects of the muta­
tion-masking activity of chaperones.
D irect and indirect effects of Hsp90 activity
Hsp90 is a chaperone engaged in late phases of protein 
folding. Substrates of Hsp90 are already partly folded; 
many of which are proteins awaiting final conformational 
changes making them active as signal transducers [65]. 
The standard role of Hsp90 is to bind and maintain these 
proteins in a conformation that enables the required 
modification to be carried out [82]. At the time when the 
concept of Hsp90-mediated masking was born, it could 
be assumed that Hsp90 performs its function by direct 
and recurrent binding and release of the assisted protein 
and that such activity would be most desirable if the pro­
tein was mutated [12]. The current understanding of sub­
strate acquisition by Hsp90 is markedly different. A 
typical protein requiring the assistance of Hsp90 is first 
bound by Hsp70 and only then transferred from Hsp70 to 
a Hsp90-centered complex [82,83]. There is no indication 
that this pattern does not apply to proteins allegedly 
engaged in phenotypic masking. Thus, Hsp90 client pro­
teins would not be exempt from the quality control typi­
cal for the substrates of Hsp70 (Fig. 3). Furthermore, it is 
difficult to imagine that a protein affected by mutation is 
chaperoned in a special way in the Hsp90 complex, if it 
gets into it, to increase the chance for required modifica­
tion [35,83]. It was mentioned above that atypical sub­
strates of Hsp90 may be instead directed towards 
degradation [79].
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Figure3
Substrate selection and processing in the eukaryotic Hsp70/Hsp90 chaperone system. Newly synthesized or sec­
ondarily unfolded proteins are recognized and bound by Hsp70. These can be either proteins that require assistance of Hsp90 
at later steps of their folding or any other polypeptides. The latter (green line) can attain their native configuration with the 
assistance of the folding Hsp70 complex [18]. or be disposed with the help of the degrading Hsp70 complex if they are exces­
sively unstable [34]. It is also possible that proteins that normally do not need to interact with Hsp90 in the process of their 
folding are nevertheless passed to the degrading Hsp90 complex when they have to be disposed [79]. Proteins that do require 
Hsp90 for the late steps of their folding (red line) can be directed to degradation before contacting this chaperone if they are 
excessively unstable [31]. Otherwise, they are passed from Hsp70 to Hsp90 through an intermediate complex containing both 
these chaperones. Maturation of these proteins can be finished in the late folding Hsp90 complex [82] or aborted in the 
degrading Hsp90 complex if they do not follow expected scenario of folding [84]. Molecules which need to be assisted by 
Hsp90 but are dropped before their fold is completed have to re-enter their path of chaperone-assisted maturation primarily, 
or perhaps exclusively through binding to the Hsp70 molecules [83]. This renders them to another round of quality control.
A revealing example of how Hsp90 actually aids protein 
quality control has been reported recently. Hsp90 is 
needed at a certain stage of maturation of CFTR. The fold­
ing of a mutant CFTR is often terminated by the quality 
control process described above, mediated by Hsp70 and 
CHIP. If  the defective CFTR is nonetheless faced with 
Hsp90, it is not yet safe. Hsp90 has a sequentially chang­
ing complement of co-chaperones. They determine the 
scenario of folding and the structure/behavior of a protein 
must conform to the expected pattern to allow efficient 
co-operation. Some mutant CFTR fall outside the range of 
tolerable incongruity and therefore the composition of 
co-chaperones of Hsp90 shifts towards factors promoting 
ubiquitylation and degradation [84]. It is possible that a 
similar evaluation is carried out for different mutations in 
different proteins and that at least some are subject to 
chaperone-assisted degradation. This was demonstrated
for mutations with relatively strong destabilizing effects, 
but there is no indication that less affected proteins are 
not disposed in this way, although probably at a lower 
rate. In sum, the general idea that Hsp90 ameliorates phe­
notypic expression of mutations by directly assisting the 
folding of destabilized proteins becomes increasingly 
incompatible with current molecular models (Fig. 3).
This conclusion is not contradicted by the experimental 
findings that phenotypic differentiation of genetically var­
iable organisms increases when the activity of Hsp90 
decreases. Hsp90 can have a few hundred client proteins 
[65]. The hypothesis of phenotypic masking was origi­
nally focused on mutations residing in these proteins. 
However, the direct clients of Hsp90 are critical for func­
tioning of many pathways in which an even larger 
number of proteins are engaged. Malfunctioning of
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Hsp90 will result in malfunctioning of its client proteins 
even if  the latter are not mutated. This, in turn, will jeop­
ardize functioning of multiple pathways, especially those 
containing mutated and therefore less efficient proteins 
[64]. In this way, the proper functioning of Hsp90, and 
other chaperones, may buffer phenotypic expression of 
mutations even if  the chaperones do not physically inter­
act with the mutated proteins. "Mutated" need not mean 
destroyed. Heritable variants of proteins whose function­
ing depends directly or indirectly on Hsp90 can give dif­
ferent phenotypic traits whenever the cellular level of this 
chaperone falls below some critical threshold. In this way, 
activity of Hsp90 buffers phenotypic expression of genetic 
variation [29,66]. It has been claimed that the depend­
ence of phenotypic variation on the activity of Hsp90 
makes this chaperone a very special capacitor of evolution
[28,37,66]. However, "release" of phenotypic variation in 
response to malfunctioning of a gene is ubiquitous and 
not restricted to Hsp90. For example, malfunctioning of 
transcriptional factors also 'uncovers' genetic variation 
because such defects are likely to lead to extensive and 
genotype-dependent changes in expression of genes. Fur­
thermore, altered functioning of chromatin remodeling 
enzymes may uncover not only genetic but also epigenetic 
variation [85]. More generally, malfunctioning of any 
gene interacting with many other genes is likely to 
increase phenotypic variation [86].
Molecular chaperones are included among the mecha­
nisms promoting stabilization because they support mul­
tiple links among proteins and in this way add to the 
overall robustness of genetic networks [87]. However, it is 
purely speculative to propose that an important factor 
governing the evolution of molecular chaperones is the 
need to increase the capability of organisms for the rapid 
remodeling of phenotypes at a time when evolutionary 
novelties are needed. According to this view, Hsp90 could 
be considered a regulator of evolvability because it can 
modulate the expression of genetic variation and in this 
way hide or expose mutations to natural selection [66,88]. 
It has been recognized that one evolutionary cost of this 
mechanism is the potential accumulation and occasional 
exposure of a number of mutations which would very 
often be harmful rather than advantageous [e.g. 
[37,66,88]]. However, any compromise in the accuracy of 
protein quality control would bring another effect, that is, 
impaired elimination of all damaged proteins, including 
those produced by non-mutated genes. Overcrowding 
and translational errors can-not be avoided. This cost 
would not be stochastic and would not increase variation. 
Instead, it would lower the fitness of all individuals in a 
population and would not promote the origin of hopeful 
variants. This is another reason for caution when suggest­
ing that molecular chaperones may serve as modulators of 
evolvability. The sensitivity of organisms to impairment
of protein quality control, especially long-lived ones, is 
increasingly well recognized in biomedicine.
M olecular chaperones and disease
The search for links between phenotypes and molecular 
mechanisms is especially difficult if  complex traits, such 
as fitness or health, are considered. For example, it was 
found that the overexpression of Hsp70 in fruit flies sup­
presses neurodegeneration caused either by proteins with 
expanded polyglutamine tracts or mutated a-synuclein 
[89,90]. In both cases the beneficial role of the Hsp70 
chaperone probably does not result from the restoration 
of the functional structures of the proteins but from a 
reduction of cytotoxicity caused by protein aggregation. 
On the one hand, this is an example of a phenotypic 
cover-up mediated by molecular chaperones. On the 
other, these phenotypically masked mutations probably 
have little bearing on future adaptation. Other examples 
come from studies on the role of Hsp90 in cancer devel­
opment. The pharmacological inhibition of this chaper­
one may lead to successful treatment [91]. Interpretation 
of this finding is not straightforward. It has been hypoth­
esized that cancer cells harbor a large amount of mutated 
proteins and therefore their functioning is dependent on 
the ability of Hsp90 to buffer multiple genetic damage 
[92]. However, the repression of Hsp90 means that not 
only mutated oncogenic proteins but also a number of 
non-mutated signal proteins are directed towards degra­
dation instead of maturation [93]. A further complication 
is that the transformed cells are faced with a stressful 
tumor microenvironment owing to hypoxia, nutrient dep­
rivation, and acidosis [94]. The most important effect of 
the repression of Hsp90, whether it is the unmasking of 
mutations, disturbance of stress response, or general 
deregulation of cellular signaling, is too complex to pin­
point at present [95]. Again, the potential adaptive value 
of mutations associated with cancer and possibly masked 
by Hsp90 is at best doubtful. We suggest that the analysis 
of the role of chaperones at the level of whole cells or 
organisms is hardly possible considering the present state 
of theory and technology. Careful examination of direct 
interactions between molecular chaperones and their 'cli­
ents' is probably a more promising way to understand 
how molecular chaperoning shapes the evolution of pro­
teins.
Chaperones and selection against m utations
Only a small fraction of single substitutions change the 
final structure of a protein so extensively that it becomes 
non-functional. Many more lead to protein variants 
whose final structure is little changed but stability is vio­
lated [96-99]. The severity of observable phenotypic 
effects can vary extensively. A mutation has to cause a rel­
atively strong, thermally dependent destabilization to 
result in a good conditional (ts, thermally sensitive) phe­
Page 9 of 16
(page number not for citation purposes)
Biology Direct 2008, 3:5 http://www.biology-direet.eom/eontent/3/1/5
notype of practical laboratory value [100]. The remaining 
mutations may have smaller phenotypic effects but are 
nevertheless susceptible to the purifying action of natural 
selection. The strength of natural selection is of course 
limited, i.e. the complete eradication of continuously aris­
ing spontaneous mutations is not expected [101]. By mag­
nifying the decrease in the cellular level of mutationally 
destabilized proteins, the chaperones would make such 
selection more effective. This would lead to a reduction of 
genetic polymorphism in populations. Insufficient 
genetic variation can limit the rate of adaptation at the 
time of environmental change [102]. Referring to the rate 
of molecular evolution, chaperones, at least in some cases, 
may slow it down by augmenting the phenotypic effects of 
amino acid substitutions and thus making more likely 
that the mutations would rather be purged by selection 
than fixed by drift. This perspective is clearly different 
from that postulating that chaperones are capacitors of 
evolution because they typically mask phenotypic expres­
sion of mutations and thus maintain a reservoir of varia­
tion needed for the creation of novelties [12,28,37,66,88]. 
At present, experimental evidence for the decrease of the 
deleterious effects of mutations as a direct result o f chap­
erone activity is restricted to bacteria under specific labo­
ratory arrangements [49,50]. Evidence for augmentation 
of mutational harm by the direct activity of chaperones is 
also restricted to a few experiments, although it is found 
both in prokaryotes and eukaryotes. Any claims about the 
domination of the former or the latter outcome would be 
premature at present.
Conclusion
Current understanding of protein folding and quality con­
trol is admittedly unsatisfactory and based on a limited 
number of examples. However, the perspective adopted 
here is supported not only by the discussed cases, but 
reflects a major conceptual shift in research on the cellular 
role of molecular chaperones. It was first established that 
the heat shock proteins are also active under normal 
metabolism and that different classes of the hsps have 
generally similar activity at the molecular level [103]. This 
leads to a model in which a nascent or destabilized pro­
tein benefits from assistance of different chaperones, each 
contributing more or less individually and additively to 
the process of folding [104,105]. In this scenario, the 
chaperones are mostly helpers. It was then gradually rec­
ognized that the chaperones function often, if not mostly, 
in assemblies which have their own structure and dynam­
ics [18,30,32,57]. The assistance provided by these 
ordered consortia of chaperones appears conditional, 
because incompatibility with the prescribed folding pro­
grams can trigger redirection to degradation [72,84]. In 
this way, the quality control o f proteins, especially large 
and complex proteins, may be extended over several steps 
of folding and maturation. This means an additional and
possibly important role of the chaperones as examiners. 
The number of chaperone-assisted folding pathways is 
probably limited, with many proteins coming through 
each of them. Participation in the same pathway means 
sharing the same folding environment. Thus, broad 
classes of proteins meet similar requirements and this can 
shape their evolution. A possible future direction in 
research is to identify particular constraints or relaxations 
that are created by different groups of chaperones. This 
would be a truly comprehensive approach to the study of 
the evolutionary role of molecular chaperones.
Reviewers' com m ents  
Reviewer's report 1
A. S. Kondrashov, University of Michigan
This is a comprehensive review of a very interesting sub­
ject. How chaperones affect evolution in general and 
selection against deleterious mutations in particular? The 
answer depends on what chaperones are doing molecu­
larly. Do they mostly help proteins to fold correctly, or do 
they mostly cause degradation of proteins that have some 
structural defects? The data are controversial and, as far as 
I can judge, the review comprehensively covers this field. 
Because the paper mostly deals with molecular mecha­
nisms, and I am an evolutionary biologist, I really have 
only two comments.
(1) Within the traditional paradigm of chaperones as 
"helpers", there still is a radical difference between chap­
erones ameliorating impacts of deleterious mutations and 
chaperones as capacitors of further evolution. Natural 
selection can easily explain the first situation, but not the 
second one. Indeed, an allele that increases fitness of indi­
viduals that carry a particular set of deleterious mutations, 
because the affected proteins fold better, will be selected 
for. In contrast, it is not clear how selection can favor an 
allele that increases the potential of the population for 
evolution in the future. Apparently, the only way this can 
happen is through group selection, which is unlikely to 
play any major role in nature.
O f course, one can argue that ameliorating impacts of del­
eterious mutations will inevitably lead to increase of the 
standing genetic variance and to more opportunities for 
evolution on the future. The first of these statements is cer­
tainly true, but the second may be wrong. The key issue is: 
how often a mutation that is currently deleterious may 
become advantageous in not-too-distant future? In other 
words, are deleterious mutations deleterious uncondi­
tionally or many of them are conditionally beneficial? 
Conventional wisdom of genetics seems to favor the first 
possibility, although there may be exceptions. However, 
this issue, which is central for our understanding of evolu­
tion, is still far from being settled.
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(2) If, in contrast, chaperones mostly work as "protein 
quality control", the reason for their evolution must be 
removal of accidentally misfolded proteins and, perhaps, 
proteins misfolded due to somatic mutations. In both 
cases, the action of chaperones must increase fitness of a 
particular genotype. Indeed, it is hard to imagine how 
selection can favor an allele that make selection against 
germline mutations more stringet, by reducing fitnesses of 
a mutation-carrying genotypes.
Reviewer's report 2
J. Hoehfeld, University of Bonn, Germany (nominated by 
A. Eyre-Walker, University of Sussex, Brighton, UK)
In their manuscript Tomala and Korona propose a signif­
icant extension of previous concepts regarding the role of 
molecular chaperones in evolution. Chaperones are cur­
rently widely viewed as capacitors of protein evolution 
because their intrinsic activity as facilitators of protein 
folding seems to enable them to maintain the function of 
mutationally destabilized proteins and, therefore, pro­
vides a means to mask or buffer the phenotypic expression 
of mutations. Tomala and Korona now argue for a re-eval­
uation of these functional concepts in particular in the 
light of recent findings that point to an active involvement 
of molecular chaperones in protein degradation. The find­
ings suggest that chaperoning of a mutationally destabi­
lized protein may not necessarily lead to the adoption of 
a functional protein structure but may result in the 
removal of the damaged protein by degradation as part of 
the cellular protein quality control. Tomala and Korona 
summarize in a comprehensive manner recent biochemi­
cal and cell biological findings regarding the cooperation 
of chaperones with protein degradation systems and then 
discuss the relevance of these findings with regard to the 
proposed role of chaperones in evolution. As such the 
manuscript represents a very interesting and stimulating 
contribution to this area of research and should be 
appealing to a broad range of researchers.
However, some aspects need further clarification. The 
authors very strongly argue against previous functional 
concepts not only on the basis of the recent findings 
regarding chaperone/proteasome cooperation, but also 
often point to mechanisms that would not involve direct 
interactions between chaperones and mutationally desta­
bilized proteins. The authors mention, for example, that a 
multitude of signaling pathways is dependent on the 
activity of the chaperone Hsp90 and accordingly pharma­
cological inhibition of Hsp90 may result in a pleiotropic 
disturbance of cell functions, resulting in the phenotypic 
unmasking of mutations without involving a direct inter­
action with the mutated proteins. Importantly, this would 
argue similarly against a role of the chaperones as folding 
factors, rescuing the mutated proteins, and against a role
as facilitators of protein degradation, removing the pro­
tein garbage, as the molecular basis for phenotypic buffer­
ing. Therefore, it seems that the manuscript should be 
restructured to separate these two aspects more clearly 
(direct interactions involving either folding or degrada­
tion versus indirect effects).
If the authors consider chaperone-assisted degradation as 
an important aspect also chaperone-assisted folding and 
rescuing should be of relevance, because we know very lit­
tle about the mechanisms that determine the eventual 
outcome of the chaperone/substrate interaction -  being it 
degradation or folding. In this regard the assessment of 
previous work pointing to the role of chaperones as capac­
itors of protein evolution seems to be overly negative. 
What is required is probably not a complete reconsidera­
tion of underlying molecular mechanisms but rather an 
extension of previous concepts, which incorporates chap­
erone-assisted degradation. Chaperone-assisted degrada­
tion of a mutationally destabilized protein could 
apparently prevent phenotypic expression because loss of 
protein function often occurs without consequences for 
viability. Mutations could accumulate on the level of the 
DNA and could be unmasked when chaperone activity 
declines for example under conditions of environmental 
stress. This would further emphasize the role of chaper­
ones as capacitors of protein evolution -  not invoking 
solely a function as folding helpers -  but considering a 
broader role as protein examiners.
M inor issues
Paragraph 'Phenotypic masking revisited': The sentence 
'the yeast co-translational Hsp40/70 system does not sup­
port functioning of mutationally destabilized proteins' 
seems to be rather bold. Do the available experimental 
data really justify this conclusion?
Regarding the increased sensitivity of cancer cells against 
Hsp90 inhibitors the authors state that it is not clear, why 
the scarcity of Hsp9 0 is more damaging to cancer cells that 
to their non-transformed counterparts. It has been 
observed, however, that Hsp90 in cancer cells displays a 
higher affinity for inhibitory drugs, resulting in the 
described differences in sensitivity
Authors' response
In line with the reviewer's suggestions we now separate more 
clearly the direct effects o f chaperone activity (stability o f pro­
teins) from indirect ones (stability o f genetic networks). This 
distinction is mentioned in the abstract and then discussed in a 
special chapter on direct and indirect effects o f Hsp90 activity. 
Indeed, the malfunctioning o f multiple metabolic pathways 
whose members depend on Hsp90 is likely to be detrimental for  
many cellular processes and protein degradation is not an 
exception. This is what we describe it as an extensive and
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largely deleterious pleiotropy. We propose, however, that a 
spontaneous change or experimental adjustment o f chaperone 
activity aimed at saving rare mutants would likely result in 
decreased quality control o f non-mutated proteins and the ensu­
ing danger o f protein misfolding and aggregation. The costs can 
be potentially high, especially for long-lived organisms. This is 
why we hesitate to accept the concept o f Hsp90 as a capacitor 
o f evolution.
While writing about 'reconsideration' we meant broadening, 
not abandonment o f previous concepts. This should be even 
more clear now after introducing a new example o f chaperone- 
mediated alleviation o f deleterious mutational effect (ts muta­
tion o f a phage coat protein -  suggested by Dr Drummond). We 
now explicitly write that a few (one or two) but genuine exam­
ples o f alleviation o f mutational damage through intensified 
interaction with chaperones can be found. Admittedly, exam­
ples o f chaperone-mediated disposal o f mutated proteins are 
also scarce. Therefore in both the former and the present man­
uscript we do not try to answer the question whether chaperones 
participate mostly in rescue or in destruction o f mutated pro­
teins. Our intention was not to "strongly argue against previous 
functional concepts". We did concentrate mostly on the involve­
ment o f chaperones in protein quality control but this was 
because this topic was insufficiently covered in the past. We do 
not mean the specialist literature on chaperones and proteolysis 
but journals on evolutionary biology.
The suggestions expressed in 'minor issues' have been accepted. 
Reviewer's report 3
D. A. Drummond, FAS Center for Systems Biology, Har­
vard University (nominated by C. Adami, California Insti­
tute o Technology, Pasadena)
The central thesis of this work is that phenotypic masking 
of mutations by chaperones has no direct empirical sup­
port when the evidence is carefully reviewed. Results from 
the Teschke lab directly contradict this position as 
described below. Taking the abstract at face value, the 
authors' program comes across as largely an attempt to 
discredit phenotypic buffering, which is unfortunate as 
they provide a valuable review of chaperone systems in 
the course of the paper. The work is elegantly written and 
polished, and should simply be refocused as a review 
which places phenotypic buffering in perspective rather 
than attempting to dismiss it.
In my reading of the literature, both supporters and 
detractors of the phenotypic buffering hypothesis accept 
that chaperones have a wide variety of roles, and support­
ers do not claim that phenotypic buffering is the primary 
activity of any chaperone. The strong argument the 
present authors seem to dislike is the claim that all chap­
erones can rescue mutation-destabilized proteins to some
degree. They make an excellent case for many distinguish­
able roles for chaperones which cannot be reduced to 
such a single common denominator, and as an answer to 
this "strong buffering principle" the present work is wel­
come. Nevertheless, I do not think the strong principle is 
widely credited.
The weak version holds that chaperones sometimes act to 
rescue mutated proteins. Against this weaker argument 
the authors's case is not particularly compelling. Consider 
the circumstantial evidence. The authors admit through­
out the manuscript how plausible it would be for chaper­
ones to rescue mutated proteins; it is difficult to disagree. 
Nonetheless, faced with the finding that mutated E. coli 
lines grow better when chaperones are abundant, and that 
other mutated lines have concomitantly increased chaper­
one levels, the authors argue ("Molecular chaperones and 
phenotypic buffering in bacteria" section, paragraph 2) 
that some mutations must have lowered the expression 
levels of proteins resulting in rate-limiting metabolic 
throttles, and some of these proteins must require chaper­
ones for maturation or remodeling. While this scenario is 
possible, I do not find it convincing at all. "Expression- 
decreasing mutations yielding rate-limiting abundance 
changes in proteins that require chaperoning for matura­
tion or remodeling" seems a much more restrictive (read: 
improbable) set than "destabilizing mutations in coding 
sequences."
More convincingly to the authors, Van Dyk et al. Nature 
(1989) reports that many ts alleles in S. typhimurium are 
suppressed by overexpression of GroEL/S (not GroEL 
alone as Tomala & Korona report). The present manu­
script admits, "Because heat sensitivity typically accompa­
nies protein instability, this result is probably the closest 
to demonstrating that chaperones can restore the func­
tionality of mutationally destabilized proteins."
A better example comes from Nakonechny and Teschke 
(JBC 1998) who show that, in vivo, 1) ts mutants of phage 
coat protein are rescued by GroEL/S overexpression; 2) 
wild-type GroEL/S supports plating efficiency (phage titer, 
a measure of phage fitness) substantially better than 
mutated versions of GroEL/S even at permissive tempera­
tures; and 3) GroEL binds directly to the destabilized coat 
proteins more than wild-type coat proteins as assessed by 
co-IP, increasingly so as a function of temperature. 
Teschke's group has also carried out elaborate experi­
ments which establish that these ts mutants are indeed 
destabilized (S.M. Doyle et al. JBC 2004).
The Teschke-group results represent a clear, complete 
story of mutant instability, chaperone rescue by direct 
interaction, and phenotypic buffering that has a direct 
impact on fitness (in this case, of the phage). This story
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directly contradicts the thesis of the present review. As a 
case in point, these results answer the concerns used to 
close the relevant paragraph: "Either phenotypic observa­
tions are convincing but molecular interpretation unsure, 
or molecular mechanisms are nearly pinpointed but their 
fitness effects unknown." I recommend that sentence be 
removed and the Teschke results reported; as stated above, 
the central thesis of the paper should be modified.
The related statement that chaperone overexpression may 
impose fitness costs ("this study did not test for possible 
negative fitness effects associated with the upregulated 
expression of chaperones") comes across as sleight-of- 
hand -  the question is first whether chaperones can buffer 
mutations, and only then if they can do so without harm­
ing the organism in other ways. The phenotypic buffering 
hypothesis covers cases in which chaperones buffer a 
mutation in an essential gene without being upregulated. 
Perhaps the authors would argue that this is impossible, 
but it is not obviously so (consider a mutation in an essen­
tial, low-expression protein which, in the absence of chap­
erones, would lead to kinetic trapping during folding, but 
which is relieved in the presence of wild-type levels of 
chaperones). As long as chaperones can render neutral 
such mutations which are otherwise deleterious, those 
mutations will go to fixation with a probability deter­
mined by population size instead of by their deleterious 
effect, and the chaperone will have effectively buffered the 
mutation in a way that contributes to evolutionary varia­
tion.
The authors' point that phenotypic buffering by Hsp90 
has yet to be directly established is well-taken. Fixation on 
Hsp90 proceeds from the original Rutherford and 
Lindquist paper, but it must be emphasized that the 
importance of that paper derived largely from the obser­
vation of morphological variants in the absence of chap­
erone -  contrast this with loss of function in the Teschke 
coat-protein mutants. (One may rightly ask whether the 
morphological variants found have any evolutionary sig­
nificance, or are just the organismal equivalent of mis- 
folding.) If the authors wish to focus on Hsp90 studies, 
they have a case; still, the possibility of phenotypic buffer­
ing by any chaperone seems to be the broader and more 
important question.
The authors improperly overlook the role of translation 
errors as by far the dominant source of mutated, destabi­
lized proteins in the cell and therefore a major relevant 
substrate of chaperones. Translational missense errors 
occur at a rate between 1e-3 and 1e-4 per codon (Ogle and 
Ramakrishnan Ann Rev Biochem 2005), so that roughly 
20% of molecules of an average-length (~400-residue) 
protein are expected to contain at least one missense error. 
For long proteins such as dynein or titin, it is likely that
most protein molecules contain at least one error. 
Mutated proteins in the cell must therefore expected to be 
common under normal physiological conditions. It seems 
plausible that many chaperones exist, in part, to rescue 
these non-heritable mutants from the premature aggrega­
tion and kinetic traps to which they are prone, so that they 
may go on to be productive members of cellular society. 
In this view, phenotypic buffering is simply an inevitable 
side-effect -  chaperones, after all, cannot tell which 
mutant proteins arose because of a DNA mutation or a 
translation error. An argument that chaperones exist *in 
order to * buffer genetic variation cannot be supported by 
this model, but I am unaware of such claims.
At any rate, I suggest that the present authors devote more 
time to discussing translation errors, perhaps using C.M. 
Grant et al. Mol Micro 1989 as jumping-off point, where 
it is shown that elevated mistranslation induced by paro­
momycin induces the heat-shock response in yeast.
As suggested above, the authors may wish to consider 
refocusing their review. My reading of the authors' evi­
dence and the literature yields a rather more accommo­
dating view than the present manuscript espouses. In 
short, the optimal strategy for the cell is to save (buffer) 
proteins which can be saved, and degrade those which 
cannot. Consider only thermodynamic stability as a nar­
row example. No amount of chaperoning can rescue a 
thermodynamically unstable protein. But because muta­
tions induce a wide range of free energy changes, some 
mutations will terminally destabilize a protein (so that it 
must be disposed of), some will marginally destabilize it 
(so that it needs chaperone help to avoid aggregation or 
degradation during folding, but no more), and some will 
leave its stability unchanged or even stabilize it (no wor­
ries!). An elaborate, connected system of chaperones must 
triage these patients, with the outcome optimally depend­
ing on the severity of the wound. Different chaperones 
may play different roles, but it must be beneficial to save 
some patients. (The authors emphasize that the reason to 
dispose of a protein may be to prevent formation of a 
toxic misfolded species rather than preserve a functioning 
protein, an argument I find very convincing and one that 
equally supports assisting the folding of some otherwise 
wobbly molecules.) The major questions concern how, 
and how well, this blind, stochastic triage system catego­
rizes its substrates, which chaperones play which (pre­
sumably overlapping) roles, and how the system can be 
recoverably or irretrievably perturbed.
Authors' response
We never claimed that genuine buffering through direct contact 
between mutated proteins and chaperones is impossible. Since 
the reviewer cites several o f our sentences, we would also like to 
cite one: "In conclusion, both the genetic data and molecular
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models suggest that chaperone-mediated masking o f protein 
structural instability in bacteria is possible." The reviewer con­
centrates on our evaluation o f experiments with bacteria. First, 
we uphold our opinion that experiments involving a large 
number o f unknown mutations are difficult to interpret. In such 
situations, low levels o f chaperones may mean insufficient 
chaperoning o f many unstable proteins. Alternatively, a syn­
thetically harmful effect may be produced through genetic inter­
action between low level o f chaperones and some null 
mutation(s).
On the other hand, we agree that the case o f a thermosensitive 
mutation in a phage coat protein provides the currently best 
example o f chaperone-mediated buffering o f mutational dam­
age. We were not familiar with this example because, as far as 
we know, it was not mentioned in the literature on phenotypic 
masking, genetic buffering, evolutionary capacitance, etc. We 
now cite this work. However, we find it difficult to acknowledge 
that the question o f costs impaired by overexpression o f chaper­
ones is less important than the fact that overexpression may 
bring about phenotypic buffering (under laboratory condi­
tions). The balance between benefits and costs is the critical fac­
tor in evolution, especially in large natural populations.
We are not aware o f previous articles that have called for recon­
sideration o f the evolutionary role o f molecular chaperones due 
to their participation in protein quality control. This function is 
by fa r  less known than the role o f chaperones in stabilization o f 
proteins and genetic networks, at least among evolutionary biol­
ogists and geneticists. Our message is not, or not only, that the 
buffering effect o f chaperone activity is rarer than believed. We 
suggest that the scarcity o f such evidence may have a deep func­
tional basis, that is, the dual role o f chaperones as both helpers 
and examiners o f proteins.
We did mention that translational errors could be a source o f 
misfolded proteins, although very briefly. We now introduce the 
requested citations and quantitative estimations o f the rate at 
which errors occur. Generally, we make clear that translational 
errors together with macromolecular overcrowding are likely to 
be a major source o f misfolding o f proteins coded by non­
mutated genes.
We did not suggest that anybody claimed that chaperones exist 
in order to buffer genetic variation. It is generally agreed that 
this can only be a secondary function. The question is whether 
this is only a side effect or a factor in their evolution. The latter 
would mean that the activity o f chaperones is tuned in a way 
that secures not only their standard functions but also allows for 
accumulation o f genetic variation. We now expand more on 
this hypothesis by referring to the concept o f Hsp90 as a 'general 
regulator o f evolvability'. This argument states that even if  the 
populations (lineages) with increased accumulation o f buffered 
mutations would be less fit  over short time scales, they would 
eventually win because o f their supremacy during periods o f
rapid adaptation. This idea is considered by many as controver­
sial and we add one more argument against it. The danger o f 
misfolding and aggregation o f proteins coded by non-mutated 
genes is probably high enough that lowering the stringency o f 
protein quality control in order to save rare mutants is unlikely. 
These evolutionary questions, and not a critique o f previous 
experimental work, are the focus o f our article. To make it obvi­
ous we rewrote the abstract and introduced several other clari­
fications.
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